Glycaemic disturbances early after MI, including hyperglycaemia below the diagnostic threshold for diabetes, are associated with a progressively higher risk of adverse outcomes, and beyond routine screening, these findings support close follow-up of at-risk patients, irrespective of diabetes status.
Abstract
Abstract Objectives This study aimed to assess cardiovascular (CV) risk across the full spectrum of dysglycaemia levels following myocardial infarction (MI). Design Retrospective registry-based cohort study. Setting All patients with MI in Sweden registered in the cardiac rehabilitation registry within the Swedish Web-system for Enhancement and Development of Evidence-based care in Heart disease Evaluated According to Recommended Therapies (SWEDEHEART) between 2006 and 2017. Participants In total, 47 558 patients over the age of 18 attending cardiac rehabilitation post-MI, with available information on glycaemic levels. Primary and secondary outcome measures The primary outcome was major adverse CV events (MACE), a composite of all-cause mortality, MI and ischaemic stroke until the end of follow-up (30 June 2018). Secondary outcomes included all the components of MACE, CV mortality and hospitalisation for heart failure. Results Pre-diabetes and possible diabetes were present in 20.6%, new-onset diabetes in 3.2% and known diabetes in 21.1%. During a median follow-up of 4.7 years, 9321 patients experienced MACE. A stepwise increase across glycaemic categories was observed, with HRs of 1.07 (95% CI 1.00 to 1.14) for pre-diabetes, 1.22 (95% CI 1.11 to 1.34) for possible diabetes, 1.22 (95% CI 1.08 to 1.37) for new-onset diabetes and 1.73 (95% CI 1.64 to 1.82) for known diabetes, compared with normoglycaemia. A near-linear association between fasting glucose and outcomes was observed across all patients, while glycated haemoglobin appears predictive mainly in those with established diabetes. Conclusions Glycaemic disturbances early after MI, including hyperglycaemia below the diagnostic threshold for diabetes, are associated with a progressively higher risk of adverse outcomes. Beyond routine screening, these findings support close follow-up of at-risk patients, irrespective of diabetes status.
We aimed to explore the association between estimated glucose disposal rate (eGDR) – a simple, non-invasive proxy for early-stage metabolic dysfunction and the risk of cardiovascular disease (CVD), major adverse cardiovascular events (MACE) and MACE plus heart failure (MACE+) among diabetes-free people.
We...
AIMS
To quantify the excess acute coronary syndrome (ACS) burden and post-ACS mortality associated with diabetes and assess LDL-C target attainment, focusing on sex differences.
METHODS
We conducted a retrospective cohort study including 5,361 patients with the first ACS admission identified during the study period (...
Gracia Cascales Guerrero, E. Chicharro-Luna, Alberto Cordero et al.· Diabetes Research and Clinic...· 0 citations
INTRODUCTION
Cardiovascular (CV) risk factors improve with carbohydrate-reduced nutrition, but the impact on CV outcomes is unknown. We assessed the incidence of CV outcomes associated with a carbohydrate-reduced telemedicine intervention in a retrospective claims-based cohort study.
METHODS
Adults with type 2 diabet...
C. Roberts, P. Shanmugam, Shaminie J. Athinarayanan et al.· Cardiology and Therapy· 0 citations
Heart failure (HF) remains a major cause of morbidity and mortality, especially in individuals with type 2 diabetes (T2D). Our ability to identify at-risk individuals, especially those without known cardiovascular disease (CVD), is still limited.
The purpose of this study was to identify early indicators o...
E. Brady, G. Gulsin, C. Razieh et al.· European Heart Journal· 0 citations
Outcomes after ST-elevation myocardial infarction (STEMI) differ between randomized controlled trials (RCTs) and real-world registries despite guideline-directed care. The cardiometabolic profiles of these populations remain incompletely illustrated. We aimed to characterize contemporary STEMI patients using detailed p...
D. Duse, J. Haurand, K. Alde et al.· Scientific Reports· 0 citations
Dysregulated serum lipids and hyperglycemia are established risk factors for adverse outcomes in acute coronary syndrome (ACS) patients after percutaneous coronary intervention (PCI). The Cholesterol, HDL, Glucose (CHG) index is a novel composite metric integrating glycemic and lipid profiles; however, its prognost...
Zai-Qiang Liu, Yu-Xiu Yang, Qiu-Xuan Li et al.· Scientific Reports· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.